Allergan is now part of AbbVie. Together, we are dedicating more to R&D to drive tomorrow’s breakthroughs while helping people live better lives today1. We deliver life-enhancing innovations to help people around the world live healthier lives2. From being the first neurotoxin to market to becoming the most studied neurotoxin in the world, BOTOX® has continued to innovate for three decades3. Over 100 million vials of BOTOX® were distributed globally, and we have created trust with physicians and patients over the past 30 years. There are 28 indications across 100 countries with more than 3900 peer-reviewed articles for BOTOX®. We will continue our innovations and leadership in neurotoxin science innovations today and in the future4.
References
1. AbbVie. (2020). AbbVie Allergan Overview. Retrieved from
2. Allergan. (2020). Our Products. Retrieved from
3. Allergan. (2020). Botox. Retrieved from
4. Allergan. (2020). Botox Endless Innovations. Retrieved from